Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProCyte
Redmond, WA, USidexx.com ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
ProCyte developed and commercialized copper peptide-based products for dermatological applications, including skin health, hair care, and wound healing. The company reported increasing revenues and cash-positive quarters in 2001 with a focus on achieving profitability by 2002. It also engaged in contract manufacturing for cGMP process development and small-scale production.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeProtein
- Industry
- Biotech
02
Partnerships
Licensees for copper-peptide technology; specifics not publicly detailed
Beyond the preview
Go deeper on ProCyte.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProCyte.